Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients.

A significant study detailing OncoSeek®'s efficacy was published in eClinicalMedicine, a clinical journal of The Lancet, titled A panel o ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a ...

MONDAY, March 24, 2025 (HealthDay News) -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to ...